axicabtagene ciloleucel
gilead sciences,daiichi sankyo
['car t', 'zuma-7', 'lymphoma', 'axi-cel']
more live coverage from today's poster sessions at #asco22: presents translational data from the randomized zuma-7 trial comparing axi-cel car t-cell therapy to chemotherapy followed by transplant in the second-line setting for large b-cell #lymphoma. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.